查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1972869

溶脂注射市场：市场洞察、竞争格局及预测（2033年）

Injection Lipolysis Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 183 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计未来几年，溶脂注射市场将稳定成长，这主要得益于消费者对非侵入性美容手术日益成长的兴趣以及对塑形方案认知度的提高。市场规模预计在2026年达到 13.3亿美元，到2033年将达到 18亿美元，年复合成长率（CAGR）为 4.3%。这一成长凸显了微创治疗的趋势，与传统手术相比，微创治疗能够更精准地减少脂肪，且恢復时间更短。

市场概览

溶脂注射是一种利用药物注射来针对局部脂肪堆积的治疗方法。它能够分解脂肪细胞，并透过人体自身的代谢过程促进脂肪的排出。最常用的药物包括脱氧胆酸和磷脂酰胆碱，它们都具有溶脂特性。由于其微创性、副作用少以及对包括腹部、大腿、上臂和颏下区域在内的多个治疗部位的有效性，该疗法备受关注。药物输送技术的创新和配方的改进进一步提升了治疗效果，增强了患者的信任度和接受度。

主要市场驱动因子

以下因素推动溶脂注射市场的扩张：

  • 1.美容意识的增强 - 社群媒体的影响、名人代言以及人们对自身外表日益成长的关注，推动了人们对无需侵入性手术即可获得明显效果的美容疗法的需求。
  • 2.非手术疗法的偏好 - 由于疼痛感更轻、併发症风险更低、恢復时间更短，患者日益寻求抽脂和其他外科减脂方法的替代方案。
  • 3.美容诊所和门诊治疗中心的扩张 - 专业皮肤科和美容机构的增加，使得更多患者能够接受溶脂注射疗法。
  • 4.技术进步 - 更安全、更有效的注射技术和药物的持续研发，提高了治疗效率和病人满意度。
  • 5.人口趋势 - 全球人口老化推动了对顽固脂肪堆积和与年龄相关的身体变化解决方案的需求，创造了新的市场需求。

新机会

溶脂注射市场为现有企业和新进业者提供了众多机会。对新型溶脂化合物、更安全的配方和先进的给药系统进行研发，可以带来显着的竞争优势。与皮肤科和美容诊所建立合作关係，并进行强调微创手术的定向行销活动，可以进一步促进溶脂注射疗法的普及。新兴市场也蕴藏着巨大的潜力，因为可支配收入的成长和人们对美容手术认知度的提高催生新的消费群体。

主要商机包括：

  • 开发新一代注射剂，以提高疗效并减少副作用。
  • 建立专门从事非手术塑形治疗的机构。
  • 利用数位行销和社群媒体平台，向病患普及溶脂注射剂的益处。
  • 与健康和预防保健机构合作，将美容疗程纳入综合健康计划。

区域洞察

北美地区在全球注射溶脂市场中处于领先地位，这得益于该地区对美容手术的高度认知、先进的医疗基础设施以及对创新疗法的积极应用。美国仍是重要的市场贡献者，各大公司持续投资于研发、行销和分销网路。

欧洲，尤其是德国、法国和英国等国家，拥有巨大的成长潜力，这主要得益于患者对微创美容解决方案的需求，以及确保安全性和有效性的严格监管标准。

亚太地区预计将实现最快成长，这主要得益于可支配收入的增加、中产阶级人口的壮大以及人们对非手术美容程序的认知度不断提高。中国、印度和韩国成为该地区的关键市场。

溶脂注射在拉丁美洲和中东、非洲地区正逐渐流行。这些地区的成长得益于因美容目的而进行的国际旅行的增加，以及提供先进塑形服务的美容和皮肤科诊所数量的增加。

竞争格局

全球溶脂注射市场竞争激烈，跨国公司和区域公司都在推动创新并扩大其业务范围。该市场的主要营运公司包括：

  • Allergan (AbbVie)
  • Cynosure (Hologic)
  • Galderma
  • Merz Aesthetics
  • SBC Aesthetic
  • Suneva Medical
  • Dermatech Corporation
  • Teoxane Laboratories
  • Biotech Pharma Group
  • Sculpture Aesthetic
  • Lumenis
  • BTL Aesthetics
  • InMode (Alma Lasers)
  • Cutera, Inc.
  • Revanesse (Prollenium Medical)

这些公司正致力于产品创新、策略联盟、併购和地理扩张，以获取市场占有率并满足日益成长的非侵入性减脂治疗需求。

市场区隔

依药物类型：

  • 脱氧胆酸
  • 磷脂酰胆碱
  • 其他

依治疗部位：

  • 脸部脂肪
  • 颏下脂肪
  • 上臂脂肪
  • 腹部脂肪
  • 大腿脂肪
  • 膝盖脂肪
  • 臀部脂肪
  • 其他

依最终用户：

  • 医院
  • 皮肤科和美容诊所
  • 门诊手术中心

依地区：

  • 北美
  • 拉丁美洲美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲

目录

第1章 执行摘要

第2章 市场概览

  • 市场定义与细分
  • 市场动态
    • 驱动因素
    • 限制因素
    • 市场机会
  • 价值链分析
  • 新冠疫情影响分析
  • 波特五力分析
  • 俄乌衝突的影响
  • PESTLE分析
  • 监理分析
  • 价格趋势分析
    • 当前价格及未来预测（2025-2033年）
    • 价格影响因素

第3章 全球溶脂注射剂市场预测，2020-2033

  • 全球溶脂注射剂市场预，依药物类型测，价值（十亿美元），2020-2033
    • 脱氧胆酸
    • 磷脂酰胆碱
    • 其他
  • 全球溶脂注射剂市场预测，依治疗部位，价值（十亿美元），2020-2033
    • 脸部脂肪
    • 颏下脂肪
    • 上臂脂肪
    • 腹部脂肪
    • 大腿脂肪
    • 膝盖脂肪
    • 臀部脂肪
    • 其他
  • 全球溶脂注射剂市场预测，依最终用户，价值（美元） （十亿美元），2020-2033年
    • 医院
    • 皮肤科和美容诊所
    • 门诊手术中心
  • 全球溶脂注射市场预测，依地区，价值（十亿美元），2020-2033年
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第4章 北美溶脂注射市场展望，2020-2033年

第5章 欧洲溶脂注射市场展望，2020-2033年

第6章 亚太地区溶脂注射市场展望，2020-2033

第7章 拉丁美洲溶脂注射剂市场展望，2020-2033年

第8章 中东与非洲溶脂注射剂市场展望，2020-2033年

第9章 竞争格局

  • 公司与细分市场热图
  • 公司市场占有率分析，2025年
  • 竞争格局概览
  • 公司简介
    • Allergan (AbbVie)
    • Cynosure (Hologic)
    • Galderma
    • Merz Aesthetics
    • SBC Aesthetic
    • Suneva Medical
    • Dermatech Corporation
    • Teoxane Laboratories
    • Biotech Pharma Group
    • Sculpture Aesthetic

第10章 附录

简介目录

The Injection Lipolysis Market is projected to experience steady growth over the coming years, driven by increasing consumer interest in non-invasive cosmetic procedures and heightened awareness of body contouring solutions. The market is estimated at USD 1.33 billion in 2026 and is expected to grow to USD 1.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.3%. This growth highlights the shift toward minimally invasive treatments that deliver targeted fat reduction with reduced recovery times compared to traditional surgical options.

Market Overview

Injection lipolysis is a procedure designed to target localized fat deposits using pharmaceutical injections, which break down fat cells for natural elimination by the body. The most widely used agents include deoxycholic acid and phosphatidylcholine, both known for their fat-dissolving properties. The procedure has gained traction due to its minimally invasive nature, limited side effects, and effectiveness across multiple treatment areas such as the abdomen, thighs, upper arms, and submental region. Innovations in drug delivery techniques and formulation improvements have further enhanced treatment outcomes, boosting patient confidence and adoption rates.

Key Market Drivers

Several factors are driving the expansion of the injection lipolysis market:

  • 1. Growing Aesthetic Awareness - Social media influence, celebrity endorsements, and rising interest in personal appearance have fueled demand for cosmetic treatments that provide visible results without invasive surgery.
  • 2. Preference for Non-Surgical Procedures - Patients increasingly seek alternatives to liposuction and other surgical fat reduction methods due to reduced pain, lower complication risks, and shorter recovery periods.
  • 3. Expansion of Cosmetic Clinics and Ambulatory Centers - The proliferation of specialized dermatology and cosmetic centers has made injection lipolysis more accessible to a wider population.
  • 4. Technological Advancements - Continuous development of safer and more effective injection techniques and formulations has improved treatment efficiency and patient satisfaction.
  • 5. Demographic Trends - The aging global population is increasingly seeking solutions for stubborn fat deposits and age-related body contour changes, creating additional demand.

Emerging Opportunities

The injection lipolysis market offers numerous opportunities for both established companies and new entrants. Research and development aimed at new fat-dissolving compounds, safer formulations, and advanced delivery systems can provide significant competitive advantages. Collaborations with dermatology and cosmetic clinics, along with targeted marketing campaigns emphasizing minimally invasive procedures, can further drive adoption. Emerging markets also offer promising potential, as growing disposable incomes and awareness of aesthetic procedures create new consumer bases.

Key business opportunities include:

  • Development of next-generation injectable compounds with higher efficacy and fewer side effects.
  • Establishing specialized centers focused exclusively on non-surgical body contouring treatments.
  • Leveraging digital marketing and social media platforms to educate patients on the benefits of injection lipolysis.
  • Partnering with wellness and preventive healthcare providers to integrate cosmetic treatments into broader wellness programs.

Regional Insights

North America leads the global injection lipolysis market due to high awareness of aesthetic procedures, advanced healthcare infrastructure, and strong adoption of innovative treatment options. The United States remains a key contributor, with major players investing in research, marketing, and distribution networks.

Europe shows significant growth potential, particularly in countries such as Germany, France, and the United Kingdom, driven by patient demand for minimally invasive cosmetic solutions and strict regulatory standards that ensure safety and efficacy.

Asia Pacific is anticipated to register the fastest growth, fueled by increasing disposable income, growing middle-class populations, and rising awareness of non-surgical aesthetic procedures. China, India, and South Korea are emerging as key markets in this region.

Latin America and the Middle East & Africa are gradually adopting injection lipolysis treatments. Growth in these regions is supported by rising aesthetic tourism and an increasing number of cosmetic and dermatology clinics offering advanced body contouring services.

Competitive Landscape

The global injection lipolysis market is competitive, with a mix of multinational corporations and regional players driving innovation and expanding reach. Key companies operating in this market include:

  • Allergan (AbbVie)
  • Cynosure (Hologic)
  • Galderma
  • Merz Aesthetics
  • SBC Aesthetic
  • Suneva Medical
  • Dermatech Corporation
  • Teoxane Laboratories
  • Biotech Pharma Group
  • Sculpture Aesthetic
  • Lumenis
  • BTL Aesthetics
  • InMode (Alma Lasers)
  • Cutera, Inc.
  • Revanesse (Prollenium Medical)

These players focus on product innovation, strategic alliances, mergers, and geographic expansion to capture market share and meet the growing demand for non-invasive fat reduction treatments.

Market Segmentation

By Drug Type:

  • Deoxycholic Acid
  • Phosphatidylcholine
  • Others

By Treatment Site:

  • Facial Fat Deposits
  • Submental Fat
  • Upper Arm Fat
  • Abdominal Fat
  • Thighs Fat
  • Knee Fat
  • Buttock Fat
  • Others

By End-User:

  • Hospitals
  • Dermatology and Cosmetic Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Injection Lipolysis Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Injection Lipolysis Market Outlook, 2020-2033

  • 3.1. Global Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Deoxycholic Acid
    • 3.1.2. Phosphatidylcholine
    • 3.1.3. Others
  • 3.2. Global Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 3.2.1. Facial Fat Deposits
    • 3.2.2. Submental Fat
    • 3.2.3. Upper Arm Fat
    • 3.2.4. Abdominal Fat
    • 3.2.5. Thighs Fat
    • 3.2.6. Knee Fat
    • 3.2.7. Buttock Fat
    • 3.2.8. Others
  • 3.3. Global Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Dermatology and Cosmetic Clinics
    • 3.3.3. Ambulatory Surgical Centers
  • 3.4. Global Injection Lipolysis Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Injection Lipolysis Market Outlook, 2020-2033

  • 4.1. North America Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Deoxycholic Acid
    • 4.1.2. Phosphatidylcholine
    • 4.1.3. Others
  • 4.2. North America Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 4.2.1. Facial Fat Deposits
    • 4.2.2. Submental Fat
    • 4.2.3. Upper Arm Fat
    • 4.2.4. Abdominal Fat
    • 4.2.5. Thighs Fat
    • 4.2.6. Knee Fat
    • 4.2.7. Buttock Fat
    • 4.2.8. Others
  • 4.3. North America Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Dermatology and Cosmetic Clinics
    • 4.3.3. Ambulatory Surgical Centers
  • 4.4. North America Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 4.4.2. U.S. Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 4.4.3. U.S. Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 4.4.4. Canada Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 4.4.5. Canada Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 4.4.6. Canada Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Injection Lipolysis Market Outlook, 2020-2033

  • 5.1. Europe Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Deoxycholic Acid
    • 5.1.2. Phosphatidylcholine
    • 5.1.3. Others
  • 5.2. Europe Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 5.2.1. Facial Fat Deposits
    • 5.2.2. Submental Fat
    • 5.2.3. Upper Arm Fat
    • 5.2.4. Abdominal Fat
    • 5.2.5. Thighs Fat
    • 5.2.6. Knee Fat
    • 5.2.7. Buttock Fat
    • 5.2.8. Others
  • 5.3. Europe Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Dermatology and Cosmetic Clinics
    • 5.3.3. Ambulatory Surgical Centers
  • 5.4. Europe Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.2. Germany Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.3. Germany Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.4. Italy Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.5. Italy Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.6. Italy Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.7. France Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.8. France Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.9. France Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.10. U.K. Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.11. U.K. Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.12. U.K. Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.13. Spain Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.14. Spain Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.15. Spain Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.16. Russia Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.17. Russia Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.18. Russia Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.19. Rest of Europe Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.20. Rest of Europe Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.21. Rest of Europe Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Injection Lipolysis Market Outlook, 2020-2033

  • 6.1. Asia Pacific Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Deoxycholic Acid
    • 6.1.2. Phosphatidylcholine
    • 6.1.3. Others
  • 6.2. Asia Pacific Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 6.2.1. Facial Fat Deposits
    • 6.2.2. Submental Fat
    • 6.2.3. Upper Arm Fat
    • 6.2.4. Abdominal Fat
    • 6.2.5. Thighs Fat
    • 6.2.6. Knee Fat
    • 6.2.7. Buttock Fat
    • 6.2.8. Others
  • 6.3. Asia Pacific Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Dermatology and Cosmetic Clinics
    • 6.3.3. Ambulatory Surgical Centers
  • 6.4. Asia Pacific Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.2. China Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.3. China Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.4. Japan Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.5. Japan Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.6. Japan Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.7. South Korea Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.8. South Korea Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.9. South Korea Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.10. India Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.11. India Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.12. India Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.13. Southeast Asia Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.14. Southeast Asia Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.15. Southeast Asia Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.16. Rest of SAO Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.17. Rest of SAO Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.18. Rest of SAO Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Injection Lipolysis Market Outlook, 2020-2033

  • 7.1. Latin America Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Deoxycholic Acid
    • 7.1.2. Phosphatidylcholine
    • 7.1.3. Others
  • 7.2. Latin America Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 7.2.1. Facial Fat Deposits
    • 7.2.2. Submental Fat
    • 7.2.3. Upper Arm Fat
    • 7.2.4. Abdominal Fat
    • 7.2.5. Thighs Fat
    • 7.2.6. Knee Fat
    • 7.2.7. Buttock Fat
    • 7.2.8. Others
  • 7.3. Latin America Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Dermatology and Cosmetic Clinics
    • 7.3.3. Ambulatory Surgical Centers
  • 7.4. Latin America Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.2. Brazil Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.3. Brazil Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 7.4.4. Mexico Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.5. Mexico Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.6. Mexico Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 7.4.7. Argentina Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.8. Argentina Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.9. Argentina Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 7.4.10. Rest of LATAM Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.11. Rest of LATAM Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.12. Rest of LATAM Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Injection Lipolysis Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Deoxycholic Acid
    • 8.1.2. Phosphatidylcholine
    • 8.1.3. Others
  • 8.2. Middle East & Africa Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 8.2.1. Facial Fat Deposits
    • 8.2.2. Submental Fat
    • 8.2.3. Upper Arm Fat
    • 8.2.4. Abdominal Fat
    • 8.2.5. Thighs Fat
    • 8.2.6. Knee Fat
    • 8.2.7. Buttock Fat
    • 8.2.8. Others
  • 8.3. Middle East & Africa Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Dermatology and Cosmetic Clinics
    • 8.3.3. Ambulatory Surgical Centers
  • 8.4. Middle East & Africa Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.2. GCC Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.3. GCC Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.4. South Africa Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.5. South Africa Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.6. South Africa Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.7. Egypt Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.8. Egypt Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.9. Egypt Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.10. Nigeria Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.11. Nigeria Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.12. Nigeria Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.13. Rest of Middle East Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.14. Rest of Middle East Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.15. Rest of Middle East Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Allergan (AbbVie)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Cynosure (Hologic)
    • 9.4.3. Galderma
    • 9.4.4. Merz Aesthetics
    • 9.4.5. SBC Aesthetic
    • 9.4.6. Suneva Medical
    • 9.4.7. Dermatech Corporation
    • 9.4.8. Teoxane Laboratories
    • 9.4.9. Biotech Pharma Group
    • 9.4.10. Sculpture Aesthetic

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations